Royce & Associates LP Neogenomics Inc Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Neogenomics Inc stock. As of the latest transaction made, Royce & Associates LP holds 639,476 shares of NEO stock, worth $9.82 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

639,476

Previous 619,696 3.19%

Holding current value

$9.82 Million

Previous $8.6 Million 9.74%

% of portfolio

0.09%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$13.4 - $17.73 $265,052 - $350,699	19,780 Added 3.19%	639,476 $9.43 Million
Q2 2024 Aug 13, 2024	BUY	$13.01 - $15.77 $582,834 - $706,480	44,799 Added 7.79%	619,696 $8.6 Million
Q1 2024 May 13, 2024	SELL	$14.06 - $16.79 $232,622 - $277,790	-16,545 Reduced 2.8%	574,897 $9.04 Million
Q4 2023 Feb 12, 2024	SELL	$11.67 - $20.73 $61,851 - $109,869	-5,300 Reduced 0.89%	591,442 $9.57 Million
Q3 2023 Nov 09, 2023	BUY	$12.15 - $17.85 $1.45 Million - $2.13 Million	119,192 Added 24.96%	596,742 $7.34 Million
Q2 2023 Aug 07, 2023	BUY	$14.1 - $19.83 $380,700 - $535,410	27,000 Added 5.99%	477,550 $7.67 Million
Q1 2023 May 04, 2023	SELL	$9.09 - $19.45 $245,430 - $525,150	-27,000 Reduced 5.65%	450,550 $7.84 Million
Q4 2022 May 23, 2023	BUY	$6.45 - $12.07 $174,150 - $325,890	27,000 Added 5.99%	477,550 $4.41 Million
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $1.87 Million - $3.49 Million	-289,200 Reduced 37.72%	477,550 $4.41 Million
Q3 2022 Nov 03, 2022	BUY	$7.86 - $12.91 $1.34 Million - $2.2 Million	170,300 Added 28.55%	766,750 $6.6 Million
Q2 2022 Aug 04, 2022	BUY	$7.06 - $13.97 $1.6 Million - $3.16 Million	226,450 Added 61.2%	596,450 $4.86 Million
Q1 2022 May 05, 2022	BUY	$12.15 - $35.28 $3.71 Million - $10.8 Million	305,000 Added 469.23%	370,000 $4.5 Million
Q3 2021 Nov 10, 2021	SELL	$41.66 - $52.52 $416,599 - $525,200	-10,000 Reduced 13.33%	65,000 $3.14 Million
Q1 2021 May 10, 2021	SELL	$41.56 - $59.88 $4.18 Million - $6.03 Million	-100,683 Reduced 57.31%	75,000 $3.62 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $449,010 - $546,480	-13,500 Reduced 7.14%	175,683 $6.48 Million
Q2 2020 Aug 07, 2020	SELL	$24.21 - $31.02 $835,245 - $1.07 Million	-34,500 Reduced 15.42%	189,183 $5.86 Million
Q1 2020 May 12, 2020	SELL	$20.5 - $34.53 $754,400 - $1.27 Million	-36,800 Reduced 14.13%	223,683 $6.18 Million
Q4 2019 Feb 06, 2020	SELL	$18.96 - $29.84 $447,835 - $704,820	-23,620 Reduced 8.31%	260,483 $7.62 Million
Q3 2019 Nov 13, 2019	SELL	$19.12 - $26.24 $3.72 Million - $5.11 Million	-194,600 Reduced 40.65%	284,103 $5.43 Million
Q2 2019 Aug 12, 2019	SELL	$19.57 - $24.1 $166,345 - $204,850	-8,500 Reduced 1.74%	478,703 $10.5 Million
Q1 2019 May 09, 2019	BUY	$12.14 - $20.46 $242,800 - $409,200	20,000 Added 4.28%	487,203 $9.97 Million
Q4 2018 Feb 11, 2019	BUY	$11.24 - $18.5 $1.6 Million - $2.64 Million	142,503 Added 43.89%	467,203 $5.89 Million
Q3 2018 Nov 13, 2018	SELL	$12.5 - $15.38 $116,250 - $143,034	-9,300 Reduced 2.78%	324,700 $4.98 Million
Q1 2018 May 14, 2018	SELL	$7.23 - $8.76 $4.06 Million - $4.92 Million	-561,900 Reduced 62.72%	334,000 $2.73 Million
Q4 2017 Feb 09, 2018	SELL	$8.02 - $11.18 $481,200 - $670,800	-60,000 Reduced 6.28%	895,900 $7.94 Million
Q2 2017 Aug 07, 2017	BUY	N/A	955,900	955,900 $8.57 Million

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.93B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Neogenomics Inc Transaction History